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ABSTRACT  
Colorectal polyp is one of important factors that have roles in developing malignancy of lower 
gastrointestinal tract. Adenomatous polyp is the most common colorectal polyps and it has been known as a 
lesion precursor for transformation process in developing gastrointestinal malignancy. Such 
transformation is known as adenocarcinoma sequence, a long-term process which usually does not 
elaborate any symptoms and remains asymptomatic. Since most colorectal polyps are asymptomatic, they are 
usually undiscovered at the time of diagnosis and results to the increasing case of malignancy 
especially the colorectal cancer.  
Considering that colorectal cancer still becomes one of the most common causes of death and 
morbidity worldwide, early detection and elimination of colorectal polyp may have a significant role in 
preventing lower gastrointestinal tract malignancy.  
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INTRODUCTION 
Colorectal polyp is an abnormal growth of tissue or  
a tumor, projecting from a mucous membrane found in  
the colon. Colorectal polyps are uncommonly  
associated with symptoms. However, it may  
occasionally cause symptoms such as rectal bleeding,  
abdominal pain, and when the size is extremely large  
then obstruction symptom may occur. Their shapes,  
sizes, and type of surfaces may various. If it is  
attached to the surface by a narrow elongated stalk,  
we call it as pedunculated polyp. If no stalk is present,  
we call it sessile polyp. Although some polyps may be  
identified macroscopically, however, histopathological  
examination should be performed to confirm  
the precise type of polyp.1,2,3 
Polyps have been known as one of important  
factors  that  potential  in  developing  lower  
gastrointestinal tract malignancy, particularly 
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the adenomatous polyps (neoplastic polyps). 
Therefore, histopathological examination becomes  
significant in clinical setting to recognize such  
malignancy potential. Screening assessment may also  
be helpful in early detection of premalignancy lesion.2,3,4  
Prompt management of colorectal polyps needs  
a comprehensive knowledge of clinical manifestation,  
anatomy, and physical examination related to their  
various histopathological types. Although most of  
colorectal polyp cases develop sporadically, but in some  
cases they may be found related to hereditary  
disorder, such as Familial Adenomatous Polyposis  
(FAP), Peutz-Jegher, Juvenile polyposis syndrome or  
Hereditary Nonpolyposis Colorectal Cancer 
(HNPCC).1,2,4 
Colorectal cancer still becomes one of the most  
common malignant cause of death and morbidity  
(± 135,000 new cases were found in United States in  
2001 and it was related to 57,000 deaths). Early  
detection and elimination of polyps may have a very  
significant role in preventing lower GI tract malignancy  
incidence.1,4  
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PREVALENCE 
The prevalence of colorectal polyps may be very  
various between each area. Autopsy studies and  
colonoscopy survey in the United States demonstrate  
that the prevalence ranges between 40-50%. Two third  
of colorectal polyp cases are adenomatous. Such  
prevalence is in line with the number of colorectal  
cancer incidences in the area, which also shows its  
strong correlation to the gastrointestinal tract  
malignancy.2,4,5 
Histopathologicaly, colorectal polyps can be 
classified into categories such as neoplastic polyp, 
non-neoplastic polyp and submucosa polyp. Despite its 
potential capacity of becoming malignant, most of 
adenomatous polyps are usually benign at the time of 
detection. They are different from the non-neoplastic 
polyps (hyperplastic, mucosa, inflammatory polyp and 
hamartomatous polyp) which usually do not have any 
potential capacity to become malignant. Finally, the last 
category is submucosa polyps (such as lymphoid, 
lyphoma, etc). By its origin, polyps are classified as 
epithelial and non-epithelial polyps.1,2,3,6 
Neoplastic Polyps (Adenomatous Polyps) 
Adenomatous polyps and hyperplastic polyps are  
the most commonly found colorectal polyp with  
a prevalence of 80-90%. The important clinical  
significance of adenomatous polyps is its potential  
capacity of becoming malignant which will develop into  
cancer by a process called adenoma-carcinoma 
sequence.1,2,3,7 
Colorectal adenoma mostly found in community  
population. A study conducted by autopsy method  
showed that its worldwide prevalence is about 22-60%.  
Whereas a colonoscopy study conducted in United  
States got the prevalence between 25-40%. 
Generally, such prevalence is mostly affected by 
geographical factors and variation of local incidence 
rate of colorectal cancer. This condition supports 
the idea of environmental influence affecting 
development of colorectal adenoma.1,3 
Age and gender also have role in developing  
colorectal adenoma. It is reported that elderly age and  
male are involved in development colorectal  
adenomatous. An autopsy study showed that 17%  
cases were found in subjects with age younger than 
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50 years, 35% cases were found in the age between 
50-59 years, 56% cases were found in the age 
between 60-69 years and 63% in the age of 70 or older. 
Another study also showed that the incidence of 
colorectal adenoma in subjects with age of 70 or older 
has reached more than 50%.1,2,3 
Colorectal adenoma usually has a small diameter  
(size < 1 cm), but it is commonly found in multiple form  
of adenomas. Increased age is strongly associated with  
the risk of multiple adenomas development.  
Colonoscopy and autopsy studies showed that colorectal  
adenoma was commonly found in distal part of colon  
and rectum, which has a similar distribution to colorectal 
cancer.1,2,8 
Epithelial adenoma is one of preneoplastic group.  
Therefore, each of such adenoma own degree of  
dysplasia. Dysplasia itself is stratified into mild,  
medium and severe. Based on histological and clinical  
manifestation, adenoma is categorized into tubular  
adenoma (≥ 75% consist of tubular component),  
villous adenoma (≥ 75% villous component),  
tubulovillous adenoma (26-75% villous component) and  
flat adenoma which is a local dysplasia without any  
projection into lumen.2,3,6,9 
Although these colorectal adenomas have potential  
capacity for being malignant, not all within this group  
progress into such transformation process. Large size  
of polyp, severe dysplasia, and villous histological  
pattern are associated with the increasing risk of its  
malignancy. National Polyp Study Workgroup 
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introduced the concept of advanced pathological 
patterns become the risk of colorectal cancer 
development; i.e. adenomatous polyp with > 1 cm in 
diameter, high-grade dysplasia, > 25% villous pattern, 
and invasive cancer.1,3,4,9 
Adenomas usually are asymptomatic and they are  
usually discovered at the time of colorectal cancer  
screening. A small adenoma unusually bleed,  
consequently the occult blood test frequently gives  
insensitive result. Positive results more likely to be  
obtained from occult blood test in pedunculated polyp,  
and it is also correlated to the size and its villous  
histological pattern.   Symptoms like hematoschezia,  
abdominal pain with altered bowel habits are not  
specified for indicating appearances of adenoma.1,3 
Non-neoplastic Polyps 
Hyperplastic polyp is the most common type of  
non-neoplastic polyps, mostly benign and does not have  
potential capacity to become malignant. It is  
predominantly found in distal part of colon and rectum,  
with a smaller size (< 0.5 cm) and sessile. Considering  
its benign characteristic, further evaluation with  
colonoscopy or surveillance is not required even after 
its finding.1,2,3,4 
Polyp mucous lining is usually thin and originated  
from normal mucosa of colon tissue. It is benign and  
can be found in colon or rectum and usually does not  
have any clinical significance.2,3 Inflammatory  
colorectal polyps are commonly associated with  
severe colon inflammation. This condition is generated  
by severe and recurrent ulceration and regeneration  
(injury repair) in colon segment and rectum. It also  
associated with other inflammatory condition such as  
Inflammatory Bowel Disease (IBD), amoebic colitis,  
ischemic colitis, schistosomiasis, dysentri, and  
sometimes without any underlying inflammatory  
process. Inflammatory polyp may have a large and  
solitaire size, so that it may cause abdominal pain and 
obstruction.1,2,3,5,6 
Hamartomatous polyps are divided into juvenile  
polyp and Peutz-Jegher polyp. Juvenile polyps usually  
appear as solid rectal polyps in children less than  
20 years of age or occasionally it may appear in  
adolescence. Most of them are pedunculated with red  
and smooth surface, and approximately 90% of cases  
appear  with  symptom  of  rectal  bleeding  
(hematoschezia). Some cases may be followed by  
abdominal pain and prolapsed of polyp out of  
the rectum.1,2 
Peutz-Jegher polyps are a non-neoplastic  
hamartomatous polyp which may occur in any part of  
gastrointestinal tract, from the stomach to rectum. It is  
usually associated with polyposes hereditary syndrome,  
but it may also found sporadically. It usually has a large  
size (> 3 cm) and it may reach 5 cm.1,3,5 Lymphoid 
polyp is a benign submucosal polyp which may occur 
due to hyperplasia of normal lymphoid tissue at the 
mucosa or submucosa of gastrointestinal tract. It is a 
result of lamina propria expansion caused by 
lymphocytic infiltration. It is usually solitaire, appears in 
rectal area, and has a small size1,2 
Lyphoma is commonly found at proximal part of  
colon or around the ileocaecal. Generally, it is solitaire,  
asymptomatic, and often discovered by chance in  
colonoscopy. Asymptomatic colon lyphoma usually  
does not require any further treatment or evaluation1,2  
Familial Adenomatous Polyposis (FAP) is one of  
genetic disorder characterized by progressive growth  
of multiple (hundreds to thousands) colorectal adenoma.  
The prevalence of FAP is approximately 1% of all  
colorectal cancer cases. The suffered patients are  
suspected to have deficiency in APC gene at the long  
arm of chromosome 5. Adenoma usually occurs at  
the first or second decade of life. In the untreated  
patients, colorectal cancer may occur in fourth or fifth  
decade of life. Gardner’s syndrome is a variant of FAP,  
characterized by adenoma and extra intestinal  
involvement.1,10 
Juvenile polyposis syndrome is a multiple  
gastrointestinal juvenile polyp, which has familial  
characteristic and approximately occurs in 25% of  
families. Familial involvement may be limited on  
stomach and colon, or it may become extensive from  
stomach to rectum. The clinical manifestation may  
include anemia, abdominal pain, rectal bleeding or  
recurrent intussusceptions. Sometimes, extra  
intestinal congenital disorders are also found to be  
involved. Patients with such familial syndrome may have  
a risk in the future likelihood of developing colon  
cancer and they are recommended to have  
colonoscopy/endoscopy surveillance to remove the 
polyp.1,10 
Peutz-Jegher’s syndrome is characterized by  
multiple hamartomatous polyps and mucocutaneus  
melanin pigmentation. The polyps usually involves small  
intestine with total number of polyp less than 100.  
Discourage feelings usually occurs in second or third  
decade of life with main symptoms of gastrointestinal  
obstruction. Patients with Peutz-Jegher’s syndrome  
have risks of developing gastrointestinal malignancy  
caused by the transformation process into adenoma.  
Therefore, it is strongly recommended to perform  
endoscopy surveillance of upper and lower gastro- 
intestinal tract, followed by polyps removal.1,2,7,8  
 Hereditary Non Polyposis Colorectal Cancer  
(HNPCC) is characterized by the growth of some  
colorectal adenoma with increasing risk of colorectal  
cancer. Adenomatous polyps in HNPCC are  
predominantly found in proximal colon and it may be  
related to possible development of extra-colon  
malignancy. Considering the high risk of being  
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malignant, periodic endoscopic surveillance for 
gastrointestinal tract is highly recommended for every 
1-2 years in patients with confirmed HNPCC.1,2,8 
GASTROINTESTINAL TRACT MALIGNANCY 
Colorectal Cancer 
Colorectal cancer is one the most common cause  
of death and morbidity in US and other Western  
countries. It is estimated that 135,000 new colorectal  
cancer cases were found in US in 2001, and it was  
related to 57,000 deaths which were associated with  
cancer. Cancer growths in a long period of time as  
a result of predisposed genetic and environmental  
factor. Therefore, early detection and early removal  
of preneoplastic initial lesion will increase the survival 
rate.4,11 
Colorectal cancer occurs through a complex  
interaction  between  affecting  genetic  and  
environmental factors. The roles of genetic factors are  
usually affected by hereditary syndrome (such as FAP  
and HNPCC); while spontaneous cancers are mostly  
affected by environment factors such as repeated  
exposure of carcinogenic condition or environment.  
In the both aforementioned conditions, the cancers do  
not occur spontaneously but it rather develops through  
a progressive process by altering mucosa of colon  
(dysplasia, adenoma, etc).4,11 
Many evidences showed the role of environmental  
factors in developing gastrointestinal tract malignancy.  
The prevalence of colorectal cancer itself extremely  
varied, from the higher incidence in North America,  
Western Europe, Australia to the lower such as in Asia,  
South America and Africa. The environmental factors  
are categorized into protective factors (high fiber  
diets, aspirin or non-steroidal anti-inflammatory drugs  
(NSAIDs) consumption, diet containing carotene,  
calcium intake, physical exercise, etc), and  
carcinogenic factors (low-fiber and high-fat diets,  
alcohol, smoking, obesity, etc). The risk of colorectal  
cancer development itself will increase in line with  
the increasing of age.4,11,12 
Individuals who have hereditary disorder such as  
FAP and HNPCC are identified as a group of persons  
who were born with susceptible genetic (hereditary)  
of colorectal cancer. In addition, the non-hereditary  
colorectal cancer (sporadic) also has still been  
influenced by genetic factors. In the last group,  
multiple mutation influenced by environmental factors  
become a trigger for developing colorectal cancer. 
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Genetic alteration that may induce the development of 
colorectal cancer can be divided into: increased  
proto-oncogene, loss of tumor suppressor gene  
activity and abnormal gene involved in the process of 
DNA repair.1,4,11,13 
The Role of Colorectal Polyp in Colorectal Cancer 
Most of colorectal cancers in the population are 
actually originated from adenomatous polyps. All 
adenoma have dysplastic epithelial cells which are 
usually benign. However, they may also have potential 
capacity to develop malignant degeneration. 
This transformation into malignant degeneration has 
been known as the adeno-carcinoma sequence. 
Usually, the transformation in sporadic adenoma lasts 
within a quite long period of time (5-15 years) which is 
different from other hereditary disorder that may 
occur in a shorter period.1,2,13 
Adenomatous polyps are related to abnormal cell  
proliferation, which acts as a basic process of  
neoplasia. This kind of abnormality arise with  
a complex process related to changes of genetic  
factors and may induce the imbalances including  
increased proto-oncogene (K-race), loss of tumor  
suppressor gene activity (APC, p53) and abnormality  
in DNA repair related gene (hMSH2, hMLH1, 
etc).1,4,11,13 
The risk of evolution from adenoma into carcinoma 
is tightly associated with the size of polyp and its 
histological characteristics. A large polyp with high 
proportion in villous architecture is more likely to be 
carcinogenic. The same possibilities also come with 
polyp containing a larger number of distortion 
architecture and atypical cells (moderate to severe 
dysplasia). A large polyp usually contains more villous 
architecture and dysplasia.2,3,6,7 
DIAGNOSIS AND MANAGEMENT 
Detection and Diagnosis 
Although the colorectal adenomatous polyps may  
cause an occult bleeding; but it is usually  
asymptomatic. The process of adeno-carcinoma  
sequence into colon and rectal malignancy develops  
slow and takes a long time before the symptoms  
occur. Consequently, polyp is one of pre-malignant  
lesion that hardly detected and it is usually discovered  
by screening for colorectal cancer. Occasionally,  
progressive polyp development may cause colorectal  
cancer-like symptoms, starting from abdominal pain to 
hematoschezia.1,6,12,14 
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Screening assessment to find the pre-cancer polyp 
or early stage of colorectal cancer in asymptomatic 
patients has become main effort to decrease mortality 
and enhance survivals. There are some methods of 
examination to detect colorectal polyp but not all of 
them may provide satisfying result in establishing 
the diagnosis. Accurate selection of diagnostic 
methods by considering cost-effectiveness principles 
may bring easier process in making diagnosis and 
organizing further management. 
Occult Blood Test 
This test is so simple, easy and cheap that some  
countries recommend it as a screening method for  
colorectal lesion (polyp/malignancy). However, this test  
has some weakness, i.e. due to its less sensitivity and  
low specificity, and negative results obtained from this  
test cannot exclude the possibility of such lesion.  
In general, polyp with a size < 1 cm does not cause  
any bleeding. Therefore, there are only approximately  
20-40% patients with polyp who have positive results 
in blood occult test.1,12,14,15,16 
Barium Enema 
Polyp can also be detected by performing 
radiological test (called barium enema), but it has 
limitations for small-sized polyps and it is not able to 
obtain biopsy tissue. The advantage of this test is due 
to its non-invasive characteristic. When it is used 
together with positive-result of occult blood test, it may 
have increased sensitivity up to 58%.4,12,15 
Rectal Sigmoidoscopy 
A number of studies indicated a significant decrease  
of mortality rate in a group that sigmoidoscopy  
examination, although it is only limited to the examined  
part of colon. Most polyps are discovered at the areas  
where it is easily reached by colonoscopy considering  
its predilection, and when there is any polyp found,  
some experts will suggest colonoscopy procedure to  
find other possible lesion at more proximal part of  
the colon. Flexible sigmoidoscopy is more efficient than  
the rigid in establishing the diagnosis of colorectal polyp.  
Due to its limitations, simultaneous use with the occult  
blood test or barium enema may increase its  
specificity and sensitivity.9,12,15 
Colonoscopy 
Until now, this test has still become a gold standard 
for detecting polyps in colon area. It is superior 
compare to other kind of tests because its capability in 
obtaining biopsy tissue and may provide therapeutic 
intervention in a time. But, considering its potential 
capability of being malignant, all polyps found in 
gastrointestinal tract by radiological examination must 
undergo histopathological examination to assure 
the possibility of malignancy occurrence. 
A part from its histological description, 
the macroscopic features of colonoscopy may also  
helpful in recognizing the type of possible polyps. For  
example, tubular adenoma has more red color in  
appearance than its adjacent tissues and it has a   smooth  
surface; while villous adenoma usually appears larger  
with a sessile, frondlike, rough and soft appearance.  
In contrast, simple mucosa polyp usually looks small  
with an appearance similar to the surrounding normal  
mucosa. Hyperplastic polyp is usually small, sessile and  
pale; whereas inflammatory polyp is usually found large,  
solitaire with inflammation signs and ulceration.2,15,17  
 The available studies indicated that colonoscopy has  
sensitivity up to ± 96%. However, some other studies  
demonstrated some of its shortcomings that in some  
cases with small-sized polyps (< 10 mm) were missed  
in colonoscopy examination. Moreover, it is also strongly  
affected by the operator’s skill, preparation prior to  
the test, cost and its invasive characteristic.2,14,15,18  
 The advanced progress of various colonoscopy  
techniques may enhance its specificity in detecting  
colon lesion. Chromoscopy and magnifying colonoscopy  
may assist further in clarifying the image of gastro- 
intestinal mucosa. Therefore, those methods may  
increase the ability of detecting small-sized polyps or  
flat-type polyps. Kato et al, demonstrated that such  
technique has 98% sensitivity and 92% specificity to  
distinguish the neoplastic/invasive with non-neoplastic/  
non-invasive lesions. Endoscopic Ultrasonography  
(EUS) may be also performed to improve ability of  
detecting suspected lesion with possible gastro- 
intestinal malignancy.12,14,17,18,19 
Virtual Colonoscopy 
Virtual colonoscopy or CT colonography is a 
non-invasive imaging method test that recently has 
developed fast as a diagnostic method for colorectal 
polyp. Some studies showed satisfaction in the results 
compare to the gold standard examination, colonoscopy, 
especially for lesion larger than 10 mm. The drawback 
of this test is the inability to get histopathological result 
and inaccuracy for the small-sized polyp (< 10 mm). 
Pickhardt et al, arranged a comparison study between 
conventional and virtual colonoscopy with the result as 
seen in the following table.14,20,21,22 
TREATMENT 
The treatment of colorectal polyp is generally  
divided into surgical and non-surgical management.  
By the advance technology in endoscopy, many  
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patients have been kept away from surgical treatment 
of colorectal polyp and such technology may also  
minimize possible risks. This method has become  
the treatment of choice due to its low complication.2,3,23  
 Polypectomy colonoscopy is an alternative  
treatment for colorectal polyp removal. It is usually  
done by using snare polypectomy, hot forceps biopsy  
and excision biopsy. Snare polypectomy is usually  
performed in pedunculated polyp, and for the small  
sessile type polyp may be treated by hot forceps  
biopsy or excision biopsy. Other technique that may  
also be performed is Endoscopic Mucosal Resection  
(EMR), a polypectomy by using saline injection (saline 
assisted polypectomy).1,2,9,24,25 
Argon plasma coagulation and laser ablation are  
other alternatives to eliminate a large number of small  
polyps that commonly found in hereditary disorder (FAP,  
HNPCC, etc), and large-sized sessile polyps with  
residues. This procedure is effective, fast and  
relatively safe if carried out by experienced expert.  
Polypectomy colonoscopy is relatively safe with low  
complication. Some post polypectomy complications that  
may occur are perforation and bleeding.9,17,24,25  
 Recently, surgical treatment to remove polyps has  
become the last choice after all colonoscopy  
procedures have been tried and only performed if there  
is malignancy features that have reached the root of  
polyp or there is no firm boundary seen within normal  
and malignant area. This action is carried out to  
remove possibilities of regional metastases and tumor  
residue. Surgical treatment may also be performed if  
polyp removal can not be done by colonoscopy  
(large-sized sessile polyp) or if there is a doubt whether  
the polyp that has been fully removed by colonoscopy  
has histological features that show a poor  
differentiation of adenocarcinoma. Surgical treatment  
to remove polyp in hereditary polyp disorder (FAP, etc)  
should be considered regarding its high risk in  
developing the gastrointestinal malignancy.1,2,3 
EVALUATION AND PREVENTION 
Further evaluation following elimination treatment  
of polyps takes an important role in preventing  
the development of gastrointestinal malignancy.  
Particularly, neoplastic polyp acts as a precursor of  
lesion for malignancy. Therefore, post-polypectomy  
surveillance must become a part of treatment  
management. After polyp elimination by polipectomy  
is carried out, it is recommended to perform  
colonoscopy surveillance in the interval of 3 to 5 years  
period following the treatment, depends on results that  
might be found. In some case, such as patients with  
large-sized sessile polyp (> 2 cm) who have 
successfully undergone excision colonoscopy, it is  
recommended to be followed up at the third and sixth  
month. Similar suggestion is also recommended for 
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patients with genetic and hereditary disorders 
(FAP, HNPCC), i.e. to have earlier screening and 
evaluation.1,3,9,26 
For the group with colorectal adenomatous polyps  
who have already undergone polyp elimination,  
a prevention effort of recurrence and malignancy  
development has been incorporated as part of  
inseparable treatment management. Life style changes  
such as low-fat and high-fiber diet, maintaining ideal  
body weight, avoiding smoking and alcohol  
consumption are some efforts to modify the risk 
factors.3,9,11,26 
Some studies demonstrated some benefits of  
consuming NSAIDs and calcium carbonate to prevent  
recurrent adenoma and to inhibit the process of  
adeno-carcinoma  sequence.  There  are  two  
mechanisms assumed to play a role as anti- 
carcinogenesis in NSAIDs, i.e. by inducing  
the apoptosis process and inhibiting the cyclooxigenase  
enzymes which are important in prostaglandin  
synthesis. A number of studies showed that  
prostaglandin has a role in tumor angiogenesis, cell  
proliferation and apoptosis inhibition. Some preliminary  
studies indicated some advantages of either  
conventional NSAIDs consumption (aspirin) or  
the selective NSAIDs such as the class of COX-2 
inhibitor.2,11,27,28 
CONCLUSION 
Colorectal polyps, particularly the adenomatous  
polyps, are a precursor of lesion which has an  
important role in developing gastrointestinal tract  
malignancy. Adenocarcinoma sequence is a long  
process and often asymptomatic so that it is frequently  
missed and resulting in increased morbidity of  
gastrointestinal tract malignancy, especially  
the colorectal cancer. Early detection and elimination  
of such precursor of lesion are very important in  
decreasing the incidence of colorectal cancer.  
 Early evaluation in colorectal cancer risk group is  
a strategy to detect lesions of early malignancy; while  
further evaluation and prevention measurements are  
inseparable parts of colorectal polyp in treatment  
management to avoid the development of colorectal  
polyps. 
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